News Channels

27 May 2017 Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)
26 May 2017 Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting NY-ESO in Combination with KEYTRUDA® (pembrolizumab) in Multiple Myeloma
26 May 2017 Health Canada Grants Approval for Ocaliva™ (obeticholic acid) for the Treatment of Patients with Primary Biliary Cholangitis (PBC)
26 May 2017 Regeneron Announces ANGPTL3/Evinacumab Publication in New England Journal of Medicine and Positive Phase 2 Data in People with HoFH
26 May 2017 Protagonist Therapeutics Initiates Phase 1 Study with Novel Hepcidin Mimetic, PTG-300
26 May 2017 Akcea Announces Publication in The New England Journal of Medicine of Data with AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects
26 May 2017 Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation
26 May 2017 Phoenix Molecular Designs Announces New Preclinical Data for Targeted Triple Negative Breast Cancer (TNBC) Therapy
26 May 2017 Phase 1 Safety Study Supports Planned Development of PCM-075 in AML
26 May 2017 BioCryst Reports Additional Positive Results From the Second Interim Analysis of Its APeX-1 Trial
26 May 2017 FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications
26 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)
26 May 2017 Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody Candidate Targeting Tau
25 May 2017 Radius Announces Positive Top-Line Results from Completed ACTIVExtend Study for TYMLOS™ in Postmenopausal Women with Osteoporosis
25 May 2017 Puma Biotechnology Receives FDA Advisory Committee Support for Neratinib
25 May 2017 U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibb’s Application for Opdivo (nivolumab) in Previously Treated Hepatocellular Carcinoma
24 May 2017 Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
24 May 2017 TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
24 May 2017 Spyryx Biosciences Reports Positive Data on SPX-101 at American Thoracic Society International Conference
24 May 2017 Pierre Fabre Pharmaceuticals Acquires Promising Assets from Igenica Biotherapeutics in the Field of Immuno-Oncology

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top